Global Diabetes Treatment Drugs Market Size, Status and Forecast 2024-2031

Report ID: 922339 | Published Date: Sep 2024 | No. of Page: 105 | Base Year: 2023 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Diabetes Treatment Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Tablets
        1.2.3 GLP-1
        1.2.4 Insulin
    1.3 Market by Application
        1.3.1 Global Diabetes Treatment Drugs Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Type 1 Diabetes
        1.3.3 Type 2 Diabetes
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Diabetes Treatment Drugs Market Perspective (2016-2027)
    2.2 Diabetes Treatment Drugs Growth Trends by Regions
        2.2.1 Diabetes Treatment Drugs Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Diabetes Treatment Drugs Historic Market Share by Regions (2016-2021)
        2.2.3 Diabetes Treatment Drugs Forecasted Market Size by Regions (2022-2027)
    2.3 Diabetes Treatment Drugs Industry Dynamic
        2.3.1 Diabetes Treatment Drugs Market Trends
        2.3.2 Diabetes Treatment Drugs Market Drivers
        2.3.3 Diabetes Treatment Drugs Market Challenges
        2.3.4 Diabetes Treatment Drugs Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Diabetes Treatment Drugs Players by Revenue
        3.1.1 Global Top Diabetes Treatment Drugs Players by Revenue (2016-2021)
        3.1.2 Global Diabetes Treatment Drugs Revenue Market Share by Players (2016-2021)
    3.2 Global Diabetes Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Diabetes Treatment Drugs Revenue
    3.4 Global Diabetes Treatment Drugs Market Concentration Ratio
        3.4.1 Global Diabetes Treatment Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Diabetes Treatment Drugs Revenue in 2020
    3.5 Diabetes Treatment Drugs Key Players Head office and Area Served
    3.6 Key Players Diabetes Treatment Drugs Product Solution and Service
    3.7 Date of Enter into Diabetes Treatment Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Diabetes Treatment Drugs Breakdown Data by Type
    4.1 Global Diabetes Treatment Drugs Historic Market Size by Type (2016-2021)
    4.2 Global Diabetes Treatment Drugs Forecasted Market Size by Type (2022-2027)

5 Diabetes Treatment Drugs Breakdown Data by Application
    5.1 Global Diabetes Treatment Drugs Historic Market Size by Application (2016-2021)
    5.2 Global Diabetes Treatment Drugs Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Diabetes Treatment Drugs Market Size (2016-2027)
    6.2 North America Diabetes Treatment Drugs Market Size by Type
        6.2.1 North America Diabetes Treatment Drugs Market Size by Type (2016-2021)
        6.2.2 North America Diabetes Treatment Drugs Market Size by Type (2022-2027)
        6.2.3 North America Diabetes Treatment Drugs Market Size by Type (2016-2027)
    6.3 North America Diabetes Treatment Drugs Market Size by Application
        6.3.1 North America Diabetes Treatment Drugs Market Size by Application (2016-2021)
        6.3.2 North America Diabetes Treatment Drugs Market Size by Application (2022-2027)
        6.3.3 North America Diabetes Treatment Drugs Market Size by Application (2016-2027)
    6.4 North America Diabetes Treatment Drugs Market Size by Country
        6.4.1 North America Diabetes Treatment Drugs Market Size by Country (2016-2021)
        6.4.2 North America Diabetes Treatment Drugs Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Diabetes Treatment Drugs Market Size (2016-2027)
    7.2 Europe Diabetes Treatment Drugs Market Size by Type
        7.2.1 Europe Diabetes Treatment Drugs Market Size by Type (2016-2021)
        7.2.2 Europe Diabetes Treatment Drugs Market Size by Type (2022-2027)
        7.2.3 Europe Diabetes Treatment Drugs Market Size by Type (2016-2027)
    7.3 Europe Diabetes Treatment Drugs Market Size by Application
        7.3.1 Europe Diabetes Treatment Drugs Market Size by Application (2016-2021)
        7.3.2 Europe Diabetes Treatment Drugs Market Size by Application (2022-2027)
        7.3.3 Europe Diabetes Treatment Drugs Market Size by Application (2016-2027)
    7.4 Europe Diabetes Treatment Drugs Market Size by Country
        7.4.1 Europe Diabetes Treatment Drugs Market Size by Country (2016-2021)
        7.4.2 Europe Diabetes Treatment Drugs Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Diabetes Treatment Drugs Market Size (2016-2027)
    8.2 Asia-Pacific Diabetes Treatment Drugs Market Size by Type
        8.2.1 Asia-Pacific Diabetes Treatment Drugs Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Diabetes Treatment Drugs Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Diabetes Treatment Drugs Market Size by Type (2016-2027)
    8.3 Asia-Pacific Diabetes Treatment Drugs Market Size by Application
        8.3.1 Asia-Pacific Diabetes Treatment Drugs Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Diabetes Treatment Drugs Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Diabetes Treatment Drugs Market Size by Application (2016-2027)
    8.4 Asia-Pacific Diabetes Treatment Drugs Market Size by Region
        8.4.1 Asia-Pacific Diabetes Treatment Drugs Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Diabetes Treatment Drugs Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Diabetes Treatment Drugs Market Size (2016-2027)
    9.2 Latin America Diabetes Treatment Drugs Market Size by Type
        9.2.1 Latin America Diabetes Treatment Drugs Market Size by Type (2016-2021)
        9.2.2 Latin America Diabetes Treatment Drugs Market Size by Type (2022-2027)
        9.2.3 Latin America Diabetes Treatment Drugs Market Size by Type (2016-2027)
    9.3 Latin America Diabetes Treatment Drugs Market Size by Application
        9.3.1 Latin America Diabetes Treatment Drugs Market Size by Application (2016-2021)
        9.3.2 Latin America Diabetes Treatment Drugs Market Size by Application (2022-2027)
        9.3.3 Latin America Diabetes Treatment Drugs Market Size by Application (2016-2027)
    9.4 Latin America Diabetes Treatment Drugs Market Size by Country
        9.4.1 Latin America Diabetes Treatment Drugs Market Size by Country (2016-2021)
        9.4.2 Latin America Diabetes Treatment Drugs Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Diabetes Treatment Drugs Market Size (2016-2027)
    10.2 Middle East & Africa Diabetes Treatment Drugs Market Size by Type
        10.2.1 Middle East & Africa Diabetes Treatment Drugs Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Diabetes Treatment Drugs Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Diabetes Treatment Drugs Market Size by Type (2016-2027)
    10.3 Middle East & Africa Diabetes Treatment Drugs Market Size by Application
        10.3.1 Middle East & Africa Diabetes Treatment Drugs Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Diabetes Treatment Drugs Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Diabetes Treatment Drugs Market Size by Application (2016-2027)
    10.4 Middle East & Africa Diabetes Treatment Drugs Market Size by Country
        10.4.1 Middle East & Africa Diabetes Treatment Drugs Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Diabetes Treatment Drugs Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Sanofi
        11.1.1 Sanofi Company Details
        11.1.2 Sanofi Business Overview
        11.1.3 Sanofi Diabetes Treatment Drugs Introduction
        11.1.4 Sanofi Revenue in Diabetes Treatment Drugs Business (2016-2021)
        11.1.5 Sanofi Recent Development
    11.2 Merck & Co.
        11.2.1 Merck & Co. Company Details
        11.2.2 Merck & Co. Business Overview
        11.2.3 Merck & Co. Diabetes Treatment Drugs Introduction
        11.2.4 Merck & Co. Revenue in Diabetes Treatment Drugs Business (2016-2021)
        11.2.5 Merck & Co. Recent Development
    11.3 Novo Nordisk
        11.3.1 Novo Nordisk Company Details
        11.3.2 Novo Nordisk Business Overview
        11.3.3 Novo Nordisk Diabetes Treatment Drugs Introduction
        11.3.4 Novo Nordisk Revenue in Diabetes Treatment Drugs Business (2016-2021)
        11.3.5 Novo Nordisk Recent Development
    11.4 Eli Lilly
        11.4.1 Eli Lilly Company Details
        11.4.2 Eli Lilly Business Overview
        11.4.3 Eli Lilly Diabetes Treatment Drugs Introduction
        11.4.4 Eli Lilly Revenue in Diabetes Treatment Drugs Business (2016-2021)
        11.4.5 Eli Lilly Recent Development
    11.5 Boehringer Ingelheim
        11.5.1 Boehringer Ingelheim Company Details
        11.5.2 Boehringer Ingelheim Business Overview
        11.5.3 Boehringer Ingelheim Diabetes Treatment Drugs Introduction
        11.5.4 Boehringer Ingelheim Revenue in Diabetes Treatment Drugs Business (2016-2021)
        11.5.5 Boehringer Ingelheim Recent Development
    11.6 Novartis
        11.6.1 Novartis Company Details
        11.6.2 Novartis Business Overview
        11.6.3 Novartis Diabetes Treatment Drugs Introduction
        11.6.4 Novartis Revenue in Diabetes Treatment Drugs Business (2016-2021)
        11.6.5 Novartis Recent Development
    11.7 Johnson & Johnson
        11.7.1 Johnson & Johnson Company Details
        11.7.2 Johnson & Johnson Business Overview
        11.7.3 Johnson & Johnson Diabetes Treatment Drugs Introduction
        11.7.4 Johnson & Johnson Revenue in Diabetes Treatment Drugs Business (2016-2021)
        11.7.5 Johnson & Johnson Recent Development
    11.8 AstraZeneca
        11.8.1 AstraZeneca Company Details
        11.8.2 AstraZeneca Business Overview
        11.8.3 AstraZeneca Diabetes Treatment Drugs Introduction
        11.8.4 AstraZeneca Revenue in Diabetes Treatment Drugs Business (2016-2021)
        11.8.5 AstraZeneca Recent Development
    11.9 Takeda
        11.9.1 Takeda Company Details
        11.9.2 Takeda Business Overview
        11.9.3 Takeda Diabetes Treatment Drugs Introduction
        11.9.4 Takeda Revenue in Diabetes Treatment Drugs Business (2016-2021)
        11.9.5 Takeda Recent Development
    11.10 Bayer
        11.10.1 Bayer Company Details
        11.10.2 Bayer Business Overview
        11.10.3 Bayer Diabetes Treatment Drugs Introduction
        11.10.4 Bayer Revenue in Diabetes Treatment Drugs Business (2016-2021)
        11.10.5 Bayer Recent Development
    11.11 Tonghua DongBao
        11.11.1 Tonghua DongBao Company Details
        11.11.2 Tonghua DongBao Business Overview
        11.11.3 Tonghua DongBao Diabetes Treatment Drugs Introduction
        11.11.4 Tonghua DongBao Revenue in Diabetes Treatment Drugs Business (2016-2021)
        11.11.5 Tonghua DongBao Recent Development
    11.12 Hua Dong
        11.12.1 Hua Dong Company Details
        11.12.2 Hua Dong Business Overview
        11.12.3 Hua Dong Diabetes Treatment Drugs Introduction
        11.12.4 Hua Dong Revenue in Diabetes Treatment Drugs Business (2016-2021)
        11.12.5 Hua Dong Recent Development
    11.13 Ganlee
        11.13.1 Ganlee Company Details
        11.13.2 Ganlee Business Overview
        11.13.3 Ganlee Diabetes Treatment Drugs Introduction
        11.13.4 Ganlee Revenue in Diabetes Treatment Drugs Business (2016-2021)
        11.13.5 Ganlee Recent Development
    11.14 Biocon
        11.14.1 Biocon Company Details
        11.14.2 Biocon Business Overview
        11.14.3 Biocon Diabetes Treatment Drugs Introduction
        11.14.4 Biocon Revenue in Diabetes Treatment Drugs Business (2016-2021)
        11.14.5 Biocon Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Diabetes Treatment Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Tablets
    Table 3. Key Players of GLP-1
    Table 4. Key Players of Insulin
    Table 5. Global Diabetes Treatment Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Diabetes Treatment Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Diabetes Treatment Drugs Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Diabetes Treatment Drugs Market Share by Regions (2016-2021)
    Table 9. Global Diabetes Treatment Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Diabetes Treatment Drugs Market Share by Regions (2022-2027)
    Table 11. Diabetes Treatment Drugs Market Trends
    Table 12. Diabetes Treatment Drugs Market Drivers
    Table 13. Diabetes Treatment Drugs Market Challenges
    Table 14. Diabetes Treatment Drugs Market Restraints
    Table 15. Global Diabetes Treatment Drugs Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Diabetes Treatment Drugs Market Share by Players (2016-2021)
    Table 17. Global Top Diabetes Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Treatment Drugs as of 2020)
    Table 18. Ranking of Global Top Diabetes Treatment Drugs Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Diabetes Treatment Drugs Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Diabetes Treatment Drugs Product Solution and Service
    Table 22. Date of Enter into Diabetes Treatment Drugs Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Diabetes Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Diabetes Treatment Drugs Revenue Market Share by Type (2016-2021)
    Table 26. Global Diabetes Treatment Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Diabetes Treatment Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Diabetes Treatment Drugs Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Diabetes Treatment Drugs Revenue Market Share by Application (2016-2021)
    Table 30. Global Diabetes Treatment Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Diabetes Treatment Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Diabetes Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Diabetes Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Diabetes Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Diabetes Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Diabetes Treatment Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Diabetes Treatment Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Diabetes Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Diabetes Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Diabetes Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Diabetes Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Diabetes Treatment Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Diabetes Treatment Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Diabetes Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Diabetes Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Diabetes Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Diabetes Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Diabetes Treatment Drugs Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Diabetes Treatment Drugs Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Diabetes Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Diabetes Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Diabetes Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Diabetes Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Diabetes Treatment Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Diabetes Treatment Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Diabetes Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Diabetes Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Diabetes Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Diabetes Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Diabetes Treatment Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Diabetes Treatment Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. Sanofi Company Details
    Table 63. Sanofi Business Overview
    Table 64. Sanofi Diabetes Treatment Drugs Product
    Table 65. Sanofi Revenue in Diabetes Treatment Drugs Business (2016-2021) & (US$ Million)
    Table 66. Sanofi Recent Development
    Table 67. Merck & Co. Company Details
    Table 68. Merck & Co. Business Overview
    Table 69. Merck & Co. Diabetes Treatment Drugs Product
    Table 70. Merck & Co. Revenue in Diabetes Treatment Drugs Business (2016-2021) & (US$ Million)
    Table 71. Merck & Co. Recent Development
    Table 72. Novo Nordisk Company Details
    Table 73. Novo Nordisk Business Overview
    Table 74. Novo Nordisk Diabetes Treatment Drugs Product
    Table 75. Novo Nordisk Revenue in Diabetes Treatment Drugs Business (2016-2021) & (US$ Million)
    Table 76. Novo Nordisk Recent Development
    Table 77. Eli Lilly Company Details
    Table 78. Eli Lilly Business Overview
    Table 79. Eli Lilly Diabetes Treatment Drugs Product
    Table 80. Eli Lilly Revenue in Diabetes Treatment Drugs Business (2016-2021) & (US$ Million)
    Table 81. Eli Lilly Recent Development
    Table 82. Boehringer Ingelheim Company Details
    Table 83. Boehringer Ingelheim Business Overview
    Table 84. Boehringer Ingelheim Diabetes Treatment Drugs Product
    Table 85. Boehringer Ingelheim Revenue in Diabetes Treatment Drugs Business (2016-2021) & (US$ Million)
    Table 86. Boehringer Ingelheim Recent Development
    Table 87. Novartis Company Details
    Table 88. Novartis Business Overview
    Table 89. Novartis Diabetes Treatment Drugs Product
    Table 90. Novartis Revenue in Diabetes Treatment Drugs Business (2016-2021) & (US$ Million)
    Table 91. Novartis Recent Development
    Table 92. Johnson & Johnson Company Details
    Table 93. Johnson & Johnson Business Overview
    Table 94. Johnson & Johnson Diabetes Treatment Drugs Product
    Table 95. Johnson & Johnson Revenue in Diabetes Treatment Drugs Business (2016-2021) & (US$ Million)
    Table 96. Johnson & Johnson Recent Development
    Table 97. AstraZeneca Company Details
    Table 98. AstraZeneca Business Overview
    Table 99. AstraZeneca Revenue in Diabetes Treatment Drugs Business (2016-2021) & (US$ Million)
    Table 100. AstraZeneca Recent Development
    Table 101. Takeda Company Details
    Table 102. Takeda Business Overview
    Table 103. Takeda Diabetes Treatment Drugs Product
    Table 104. Takeda Revenue in Diabetes Treatment Drugs Business (2016-2021) & (US$ Million)
    Table 105. Takeda Recent Development
    Table 106. Bayer Company Details
    Table 107. Bayer Business Overview
    Table 108. Bayer Diabetes Treatment Drugs Product
    Table 109. Bayer Revenue in Diabetes Treatment Drugs Business (2016-2021) & (US$ Million)
    Table 110. Bayer Recent Development
    Table 111. Tonghua DongBao Company Details
    Table 112. Tonghua DongBao Business Overview
    Table 113. Tonghua DongBao Diabetes Treatment Drugs Product
    Table 114. Tonghua DongBao Revenue in Diabetes Treatment Drugs Business (2016-2021) & (US$ Million)
    Table 115. Tonghua DongBao Recent Development
    Table 116. Hua Dong Company Details
    Table 117. Hua Dong Business Overview
    Table 118. Hua Dong Diabetes Treatment Drugs Product
    Table 119. Hua Dong Revenue in Diabetes Treatment Drugs Business (2016-2021) & (US$ Million)
    Table 120. Hua Dong Recent Development
    Table 121. Ganlee Company Details
    Table 122. Ganlee Business Overview
    Table 123. Ganlee Diabetes Treatment Drugs Product
    Table 124. Ganlee Revenue in Diabetes Treatment Drugs Business (2016-2021) & (US$ Million)
    Table 125. Ganlee Recent Development
    Table 126. Biocon Company Details
    Table 127. Biocon Business Overview
    Table 128. Biocon Diabetes Treatment Drugs Product
    Table 129. Biocon Revenue in Diabetes Treatment Drugs Business (2016-2021) & (US$ Million)
    Table 130. Biocon Recent Development
    Table 131. Research Programs/Design for This Report
    Table 132. Key Data Information from Secondary Sources
    Table 133. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Diabetes Treatment Drugs Market Share by Type: 2020 VS 2027
    Figure 2. Tablets Features
    Figure 3. GLP-1 Features
    Figure 4. Insulin Features
    Figure 5. Global Diabetes Treatment Drugs Market Share by Application: 2020 VS 2027
    Figure 6. Type 1 Diabetes Case Studies
    Figure 7. Type 2 Diabetes Case Studies
    Figure 8. Diabetes Treatment Drugs Report Years Considered
    Figure 9. Global Diabetes Treatment Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 10. Global Diabetes Treatment Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Diabetes Treatment Drugs Market Share by Regions: 2020 VS 2027
    Figure 12. Global Diabetes Treatment Drugs Market Share by Regions (2022-2027)
    Figure 13. Global Diabetes Treatment Drugs Market Share by Players in 2020
    Figure 14. Global Top Diabetes Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Treatment Drugs as of 2020
    Figure 15. The Top 10 and 5 Players Market Share by Diabetes Treatment Drugs Revenue in 2020
    Figure 16. Global Diabetes Treatment Drugs Revenue Market Share by Type (2016-2021)
    Figure 17. Global Diabetes Treatment Drugs Revenue Market Share by Type (2022-2027)
    Figure 18. North America Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 19. North America Diabetes Treatment Drugs Market Share by Type (2016-2027)
    Figure 20. North America Diabetes Treatment Drugs Market Share by Application (2016-2027)
    Figure 21. North America Diabetes Treatment Drugs Market Share by Country (2016-2027)
    Figure 22. United States Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Canada Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Diabetes Treatment Drugs Market Share by Type (2016-2027)
    Figure 26. Europe Diabetes Treatment Drugs Market Share by Application (2016-2027)
    Figure 27. Europe Diabetes Treatment Drugs Market Share by Country (2016-2027)
    Figure 28. Germany Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. France Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. U.K. Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Italy Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Russia Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Nordic Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Diabetes Treatment Drugs Market Share by Type (2016-2027)
    Figure 36. Asia-Pacific Diabetes Treatment Drugs Market Share by Application (2016-2027)
    Figure 37. Asia-Pacific Diabetes Treatment Drugs Market Share by Region (2016-2027)
    Figure 38. China Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Japan Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. South Korea Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Southeast Asia Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. India Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Australia Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Diabetes Treatment Drugs Market Share by Type (2016-2027)
    Figure 46. Latin America Diabetes Treatment Drugs Market Share by Application (2016-2027)
    Figure 47. Latin America Diabetes Treatment Drugs Market Share by Country (2016-2027)
    Figure 48. Mexico Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Brazil Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Diabetes Treatment Drugs Market Share by Type (2016-2027)
    Figure 52. Middle East & Africa Diabetes Treatment Drugs Market Share by Application (2016-2027)
    Figure 53. Middle East & Africa Diabetes Treatment Drugs Market Share by Country (2016-2027)
    Figure 54. Turkey Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Saudi Arabia Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. UAE Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Sanofi Revenue Growth Rate in Diabetes Treatment Drugs Business (2016-2021)
    Figure 58. Merck & Co. Revenue Growth Rate in Diabetes Treatment Drugs Business (2016-2021)
    Figure 59. Novo Nordisk Revenue Growth Rate in Diabetes Treatment Drugs Business (2016-2021)
    Figure 60. Eli Lilly Revenue Growth Rate in Diabetes Treatment Drugs Business (2016-2021)
    Figure 61. Boehringer Ingelheim Revenue Growth Rate in Diabetes Treatment Drugs Business (2016-2021)
    Figure 62. Novartis Revenue Growth Rate in Diabetes Treatment Drugs Business (2016-2021)
    Figure 63. Johnson & Johnson Revenue Growth Rate in Diabetes Treatment Drugs Business (2016-2021)
    Figure 64. AstraZeneca Revenue Growth Rate in Diabetes Treatment Drugs Business (2016-2021)
    Figure 65. Takeda Revenue Growth Rate in Diabetes Treatment Drugs Business (2016-2021)
    Figure 66. Bayer Revenue Growth Rate in Diabetes Treatment Drugs Business (2016-2021)
    Figure 67. Tonghua DongBao Revenue Growth Rate in Diabetes Treatment Drugs Business (2016-2021)
    Figure 68. Hua Dong Revenue Growth Rate in Diabetes Treatment Drugs Business (2016-2021)
    Figure 69. Ganlee Revenue Growth Rate in Diabetes Treatment Drugs Business (2016-2021)
    Figure 70. Biocon Revenue Growth Rate in Diabetes Treatment Drugs Business (2016-2021)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sanofi
Merck & Co.
Novo Nordisk
Eli Lilly
Boehringer Ingelheim
Novartis
Johnson & Johnson
AstraZeneca
Takeda
Bayer
Tonghua DongBao
Hua Dong
Ganlee
Biocon
Frequently Asked Questions
Diabetes Treatment Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Diabetes Treatment Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Diabetes Treatment Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Dementia Treatment

Donepezil (also known as Aricept), rivastigmine (Exelon) and galantamine (Reminyl) are used to t ... Read More